Achillion Pharmaceuticals, Inc. Less Attractive Amid Johnson & Johnson/Alios BioPharma Deal
September 30, 2014 at 12:19 PM EDT
Following the announcement of the Johnson & Johnson's (NYSE: JNJ) $1.75 billion cash deal for privately held Alios BioPharma, ...